What is a good medicine to take for myasthenia gravis?

Written by Zhang Hui
Neurology
Updated on September 21, 2024
00:00
00:00

Myasthenia gravis is an autoimmune disease of the nervous system. Patients need to take medication for a long time, otherwise, antibodies to acetylcholine receptors might continue to be produced, further worsening the clinical manifestations. The medications taken by patients with myasthenia gravis mainly include the following types, the first being cholinesterase inhibitors. These drugs can inhibit the breakdown of acetylcholine by cholinesterase, thereby improving the transmission function between nerve and muscle junctions, and improving the clinical symptoms of patients. It is best to take these medications before meals for better absorption. The second type of medication mainly includes corticosteroids. They can suppress the body's immune response and reduce the production of antibodies, which is very helpful for the recovery from the disease. Long-term usage and gradual dosage reduction are necessary. Additionally, some immunosuppressants need to be taken. Taking these immunosuppressants also aims to suppress the immune response. However, it is essential to be aware of their adverse effects, such as suppression of bone marrow function, and damage to liver and kidney functions.

Other Voices

doctor image
home-news-image
Written by Zhang Hui
Neurology
55sec home-news-image

Early symptoms of myasthenia gravis

Myasthenia gravis is an autoimmune disease of the nervous system that primarily affects the acetylcholine receptors on the postsynaptic membrane, causing muscle fatigue in patients. This can lead to general weakness throughout the body, double vision, and even progressive paralysis of the respiratory muscles, requiring active breathing assistance in severe cases. The early symptoms of myasthenia gravis mainly include: First, patients tend to fatigue easily, such as after exercise or labor, with a rapid decline in physical strength that only recovers after resting. Second, there may be ptosis, with patients unable to comfortably open their eyes, although this symptom can improve after resting or sleeping. As myasthenia gravis progresses into its later stages, there is a marked increase in overall weakness, necessitating treatment in a neurology department.

doctor image
home-news-image
Written by Liu Hong Mei
Neurology
51sec home-news-image

Will severe myasthenia gravis swallowing difficulties improve?

Myasthenia gravis and difficulty swallowing generally improve with medication treatment. Myasthenia gravis is a neuromuscular disease that typically presents with worsened muscle weakness and swallowing difficulties during fatigue. This condition requires targeted pharmacological treatment and further repetitive stimulation, which can involve specific medications and steroids. Swallowing difficulties associated with myasthenia gravis are typical of generalized myasthenia gravis, necessitating active pharmaceutical treatment, which usually has good outcomes. Avoid overworking, staying up too late, smoking, and excessive drinking. It is important to rest sufficiently, ensure ample sleep, eat fresh vegetables and fruits, and consume high-protein, nutritious foods.

doctor image
home-news-image
Written by Zhang Hui
Neurology
52sec home-news-image

Myasthenia gravis often co-occurs with which diseases?

Myasthenia gravis is a type of autoimmune disease of the nervous system, mainly caused by the production of abnormal antibodies in the body. These antibodies affect the acetylcholine receptors in the postsynaptic membrane, thereby impacting the transmission of nerve impulses at the neuromuscular junction. Being an autoimmune disease, myasthenia gravis usually coincides with the following conditions: The first major category is thymus diseases, with most patients experiencing thymic hyperplasia, and particularly, there may be cases of thymoma. If there is a thymoma, it is advised to undergo surgical treatment promptly. The second major category may involve hyperthyroidism, so it is essential to test thyroid function. Thirdly, some patients may also test positive for antinuclear antibodies, which requires careful differential diagnosis.

doctor image
home-news-image
Written by Zhang Hui
Neurology
56sec home-news-image

What is myasthenia gravis?

Myasthenia gravis is a group of neuromuscular junction disorders and is also an autoimmune disease of the nervous system. It primarily involves the production of certain antibodies in the body that attack the acetylcholine receptors on the postsynaptic membrane of the neuromuscular junction. This results in the inability of nerve impulses to be effectively transmitted to the muscles, causing the muscles to lose neural control, leading to weakness of the limbs. This weakness is typically more pronounced in the evening than in the morning, with symptoms being lighter upon waking and worsening in the afternoon. As the disease is caused by an autoimmune response, a major focus of treatment is to suppress this abnormal immune reaction, primarily through the administration of corticosteroids. Additionally, many patients with myasthenia gravis also exhibit thymus abnormalities, necessitating thorough CT examinations of the thymus.

doctor image
home-news-image
Written by Tang Li Li
Neurology
1min 2sec home-news-image

Myasthenia gravis should be seen in the Neurology department.

Patients with myasthenia gravis should consult the department of neurology, as myasthenia gravis is an immune-related neuromuscular junction disorder. Patients often exhibit pathological fatigue, skeletal muscle involvement, and unaffected smooth muscles. The most common type is ocular myasthenia, followed by mild and moderate generalized forms. Adult patients often have thymomas or thymic hyperplasia. Upon diagnosis of myasthenia gravis, it is essential to perform a comprehensive thymic CT scan. If thymic abnormalities are present, referral to thoracic surgery for treatment is needed. If there is no thymic disease, high-dose steroid pulse therapy may be considered. Additionally, it is crucial to determine whether the patient has other coexisting immune abnormalities, such as hyperthyroidism or connective tissue disease, and tailor the treatment accordingly.